Literature DB >> 1316390

Rhinovirus 39 infection in allergic and nonallergic subjects.

W J Doyle1, D P Skoner, P Fireman, J T Seroky, I Green, F Ruben, D R Kardatzke, J M Gwaltney.   

Abstract

To determine if individuals with allergic rhinitis are hyperresponsive to upper respiratory tract viral infections, 20 allergic and 18 nonallergic, susceptible, adult volunteers were challenged and infected with rhinovirus type 39 before the pollen seasons. Before challenge and on each of 6 days of cloister, all volunteers were interviewed for symptoms and completed a test battery consisting of evaluations of secretion production by weighed tissues, nasal patency by active posterior rhinomanometry, nasal clearance by the dyed saccharin technique, pulmonary function by spirometry, eustachian tube function by sonotubometry, and middle ear status by tympanometry. The symptomatology and pathophysiology resulting from the rhinovirus infection were consistent with those reported in previous studies with this challenge system. Between-group comparisons revealed no differences in symptom presentation, nasal secretion production, or overall pathophysiologic response. However, for decreased mucociliary clearance rate, increased nasal congestion, eustachian tube dysfunction, and symptoms of sneezing, the allergic group demonstrated an earlier onset compared with that of the nonallergic group. The biologic significance of the differences in onset of dysfunction is tempered by the observation that the temporal pattern of responses in the allergic group was similar with that of nonallergic subjects in previous studies. The results of the present study do not support the hypothesis of a physiologic hyperresponsiveness to rhinovirus type 39 infection in allergic subjects during nonallergy seasons.

Entities:  

Mesh:

Year:  1992        PMID: 1316390      PMCID: PMC7133183          DOI: 10.1016/0091-6749(92)90219-r

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  23 in total

1.  Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy.

Authors:  W J Doyle; S Boehm; D P Skoner
Journal:  J Allergy Clin Immunol       Date:  1990-12       Impact factor: 10.793

2.  Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds.

Authors:  M J Gaffey; J M Gwaltney; W E Dressler; J V Sorrentino; F G Hayden
Journal:  Am Rev Respir Dis       Date:  1987-01

3.  Nasal histamine sensitivity in allergic rhinitis.

Authors:  M Okuda; H Ohtsuka; K Sakaguchi; T Watase
Journal:  Ann Allergy       Date:  1983-07

4.  Role of nasal allergy in chronic maxillary sinusitis--diagnostic value of nasal challenge with allergen.

Authors:  Z Pelikan; M Pelikan-Filipek
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

Review 5.  Regulation of the IgE system: experimental and clinical aspects.

Authors:  D H Katz
Journal:  Allergy       Date:  1984-02       Impact factor: 13.146

6.  The role of IgE mediated hypersensitivity in recurrent otitis media with effusion.

Authors:  J M Bernstein; J Lee; K Conboy; E Ellis; P Li
Journal:  Am J Otol       Date:  1983-07

7.  Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls.

Authors:  R Gerth Van Wijk; P H Dieges
Journal:  Clin Allergy       Date:  1987-11

8.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions.

Authors:  R F Lemanske; E C Dick; C A Swenson; R F Vrtis; W W Busse
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

9.  Nasal responsiveness to methacholine stimulation in allergic rhinitis patients.

Authors:  K Asakura; K Enomoto; H Ara; E Azuma; A Kataura
Journal:  Arch Otorhinolaryngol       Date:  1984

10.  An introduction to allergic disease.

Authors:  M Haeney
Journal:  J R Coll Physicians Lond       Date:  1985-07
View more
  17 in total

1.  Viral respiratory infection and the link to asthma.

Authors:  James E Gern
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

2.  Rhinovirus disrupts the barrier function of polarized airway epithelial cells.

Authors:  Umadevi Sajjan; Qiong Wang; Ying Zhao; Dieter C Gruenert; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

3.  Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects.

Authors:  R M Wadowsky; S M Mietzner; D P Skoner; W J Doyle; P Fireman
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

4.  Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness.

Authors:  H Hakonarson; N Maskeri; C Carter; R L Hodinka; D Campbell; M M Grunstein
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

5.  Eustachian tube opening measured by sonotubometry is poorer in adults with a history of past middle ear disease.

Authors:  Miriam S Teixeira; Juliane Banks; J Douglas Swarts; Cuneyt M Alper; William J Doyle
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-01-13       Impact factor: 1.675

6.  Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group.

Authors:  W M Lee; W Wang; R R Rueckert
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

Review 7.  The Role of Environmental Risk Factors on the Development of Childhood Allergic Rhinitis.

Authors:  Allison C Wu; Amber Dahlin; Alberta L Wang
Journal:  Children (Basel)       Date:  2021-08-17

Review 8.  Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility?

Authors:  Kristina M James; R Stokes Peebles; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2012-08       Impact factor: 10.793

9.  The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness.

Authors:  William J Doyle; Margaretha L Casselbrant; Ha-Sheng Li-Korotky; Allison P Cullen Doyle; Chia-Yee Lo; Ronald Turner; Sheldon Cohen
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

10.  Recalled Neighborhood Environments, Parental Control, and Cytokine-Mediated Response to Viral Challenge.

Authors:  Kelsey L Corallo; Sarah M Lyle; Michael L M Murphy; Michelle R vanDellen; Katherine B Ehrlich
Journal:  Psychosom Med       Date:  2021-10-01       Impact factor: 3.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.